Literature DB >> 16988795

Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects.

J Roggenbach1, B Müller-Oerlinghausen, L Franke, R Uebelhack, S Blank, B Ahrens.   

Abstract

BACKGROUND: A robust association between "suicidality" and deficits of the serotoninergic neurotransmission has been claimed in the past. However, many studies having investigated the relationship between suicidality and peripheral indicators of serotoninergic neurotransmission suffer from considering only one or a very small number of potentially useful serotoninergic parameters, whereas a synoptic multidimensional approach appears to be more appropriate. Furthermore, the psychiatric context within which suicidal behaviour occurs should be considered when interpreting biochemical findings of patients with suicidal ideation and suicide attempts.
METHODS: In the present study 5 peripheral serotonergic markers, (platelet 5HT concentration, 5HT uptake activity, 5HT(2A) receptor binding characteristics, MAO-B activity and tryptophan concentration in plasma) were assessed simultaneously. Of the 60 acutely suicidal inpatients (ICD-10: F43.xx, n = 52; F31/32/33, n = 8), 45 were suicide attempters. Data of 28 nonsuicidal patients with major depression (F31, n = 4; F32, n = 14; F33, n = 10) and 123 healthy volunteers represented the control groups.
RESULTS: Mean platelet 5HT concentration was significantly lower in suicidal inpatients when compared to nonsuicidal depressed patients, but did not differ from the figure in healthy subjects. Nonsuicidal depressed patients showed significantly higher mean platelet-5HT concentration than healthy controls. Mean V(max) of 5HT uptake in washed platelets, but not in platelet-rich plasma, was significantly higher in suicidal patients than in healthy controls, not, however, when compared to nonsuicidal depressed patients. Mean K(D) for the platelet 5HT(2A) receptor and MAO-B activity were significantly lower in suicidal patients as compared to nonsuicidal depressed patients and healthy controls. The observed differences in peripheral serotonergic markers between groups are partially due to a significant gender effect. A lower MAO-B activity was observed only in suicidal females, while the higher V(max) of 5HT uptake in washed platelets of suicidal patients was due to suicidal males.
CONCLUSIONS: In view of conflicting observations made by other authors and the present findings on suicidal patients with adjustment disorder it remains doubtful whether and if so to which extent platelet studies can provide valid information on serotonergic mechanisms related to suicidal behaviour.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16988795     DOI: 10.1007/s00702-006-0555-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  66 in total

1.  Low blood cholesterol and low platelet serotonin levels in violent suicide attempters.

Authors:  J C Alvarez; D Cremniter; P Lesieur; A Gregoire; A Gilton; I Macquin-Mavier; C Jarreau; O Spreux-Varoquaux
Journal:  Biol Psychiatry       Date:  1999-04-15       Impact factor: 13.382

2.  Upregulation of the platelet Serotonin2A receptor and low blood serotonin in suicidal psychiatric patients.

Authors:  M L Rao; B Hawellek; A Papassotiropoulos; A Deister; C Frahnert
Journal:  Neuropsychobiology       Date:  1998       Impact factor: 2.328

3.  Seasonal influence on platelet 5-HT levels in patients with recurrent major depression and schizophrenia.

Authors:  M Jakovljević; D Mück-Seler; N Pivac; D Ljubicić; M Bujas; G Dodig
Journal:  Biol Psychiatry       Date:  1997-05-15       Impact factor: 13.382

4.  Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.

Authors:  P D Hrdina; D Bakish; A Ravindran; J Chudzik; P Cavazzoni; Y D Lapierre
Journal:  Psychiatry Res       Date:  1997-02-07       Impact factor: 3.222

5.  Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior.

Authors:  G N Pandey; S C Pandey; Y Dwivedi; R P Sharma; P G Janicak; J M Davis
Journal:  Am J Psychiatry       Date:  1995-06       Impact factor: 18.112

6.  Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).

Authors:  R Uebelhack; L Franke; H J Schewe
Journal:  Pharmacopsychiatry       Date:  1998-09       Impact factor: 5.788

7.  Platelet 5-HT concentrations and suicidal behaviour in recurrent major depression.

Authors:  D Mück-Seler; M Jakovljević; N Pivac
Journal:  J Affect Disord       Date:  1996-06-20       Impact factor: 4.839

8.  Tissue-specific effects of estrogen on monoamine oxidase A and B in the rat.

Authors:  D P Holschneider; T Kumazawa; K Chen; J C Shih
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

9.  The relationship of platelet 5-HT2 receptor indices to major depressive disorder, personality traits, and suicidal behavior.

Authors:  P A McBride; R P Brown; M DeMeo; J Keilp; T Mieczkowski; J J Mann
Journal:  Biol Psychiatry       Date:  1994-03-01       Impact factor: 13.382

10.  Platelet serotonin and plasma tryptophan in depressed patients: effect of drug treatment and clinical outcome.

Authors:  F Karege; J Widmer; P Bovier; J M Gaillard
Journal:  Neuropsychopharmacology       Date:  1994-05       Impact factor: 7.853

View more
  10 in total

Review 1.  Influence of mental stress on platelet bioactivity.

Authors:  Pia Koudouovoh-Tripp; Barbara Sperner-Unterweger
Journal:  World J Psychiatry       Date:  2012-12-22

2.  Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder.

Authors:  M Elizabeth Sublette; Hanga C Galfalvy; Dietmar Fuchs; Manana Lapidus; Michael F Grunebaum; Maria A Oquendo; J John Mann; Teodor T Postolache
Journal:  Brain Behav Immun       Date:  2011-05-14       Impact factor: 7.217

3.  The role of the kynurenine pathway in suicidality in adolescent major depressive disorder.

Authors:  Kailyn A L Bradley; Julia A C Case; Omar Khan; Thomas Ricart; Amira Hanna; Carmen M Alonso; Vilma Gabbay
Journal:  Psychiatry Res       Date:  2015-04-01       Impact factor: 3.222

4.  Inflammation and nitro-oxidative stress in current suicidal attempts and current suicidal ideation: a systematic review and meta-analysis.

Authors:  Asara Vasupanrajit; Ketsupar Jirakran; Chavit Tunvirachaisakul; Marco Solmi; Michael Maes
Journal:  Mol Psychiatry       Date:  2022-01-08       Impact factor: 13.437

5.  The 5-HTTLPR polymorphism, platelet serotonin transporter activity and platelet serotonin content in underweight and weight-recovered females with anorexia nervosa.

Authors:  Stefan Ehrlich; Leonora Franke; Susann Scherag; Roland Burghardt; Regina Schott; Nora Schneider; Simone Brockhaus; Jakob Hein; Ralf Uebelhack; Ulrike Lehmkuhl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-12-03       Impact factor: 5.270

Review 6.  Biological basis of suicide and suicidal behavior.

Authors:  Ghanshyam N Pandey
Journal:  Bipolar Disord       Date:  2013-06-15       Impact factor: 6.744

7.  Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans.

Authors:  Andrea M Dlugos; Abraham A Palmer; Harriet de Wit
Journal:  J Neural Transm (Vienna)       Date:  2009-08-06       Impact factor: 3.575

Review 8.  Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other Approaches.

Authors:  Rayan K Al Jurdi; Alan Swann; Sanjay J Mathew
Journal:  Curr Psychiatry Rep       Date:  2015-10       Impact factor: 5.285

9.  PLATELET SEROTONIN AS BIOMARKER FOR ASSESSING SUICIDAL BEHAVIOUR IN PATIENTS WITH BIPOLAR I DISORDER.

Authors:  A Giurgiuca; S Schipor; A Caragheorgheopol; A Crasan; E Postolache; C Tudose; D Prelipceanu; D Cozman
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jul-Sep       Impact factor: 0.877

10.  Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach.

Authors:  A B Niculescu; D F Levey; P L Phalen; H Le-Niculescu; H D Dainton; N Jain; E Belanger; A James; S George; H Weber; D L Graham; R Schweitzer; T B Ladd; R Learman; E M Niculescu; N P Vanipenta; F N Khan; J Mullen; G Shankar; S Cook; C Humbert; A Ballew; M Yard; T Gelbart; A Shekhar; N J Schork; S M Kurian; G E Sandusky; D R Salomon
Journal:  Mol Psychiatry       Date:  2015-08-18       Impact factor: 15.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.